Double-Blind Placebo-Controlled Pilot Investigation of the Safety of a Single Dose of Rapid-Acting Intranasal Insulin in Down Syndrome.

Autor: Rosenbloom, Michael1,2 (AUTHOR) Michael.H.Rosenbloom@HealthPartners.Com, Barclay, Terry1 (AUTHOR), Johnsen, Justin1 (AUTHOR), Erickson, Lauren2 (AUTHOR), Svitak, Aleta1 (AUTHOR), Pyle, Maria1 (AUTHOR), Frey, William1,2 (AUTHOR), Hanson, Leah R.1,2 (AUTHOR)
Zdroj: Drugs in R&D. Mar2020, Vol. 20 Issue 1, p11-15. 5p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje